[Team medical care for lymphedema management from evidence-based medicine].
Identifieur interne : 002285 ( Main/Curation ); précédent : 002284; suivant : 002286[Team medical care for lymphedema management from evidence-based medicine].
Auteurs : Kaoru Kitamura ; Miyuki KawamotoSource :
- Gan to kagaku ryoho. Cancer & chemotherapy [ 0385-0684 ] ; 2014.
Descripteurs français
- KwdFr :
- MESH :
- effets indésirables : Lymphadénectomie.
- étiologie : Lymphoedème.
- Complications postopératoires, Guides de bonnes pratiques cliniques comme sujet, Humains, Lymphoedème, Médecine factuelle, Équipe soignante.
English descriptors
- KwdEn :
- MESH :
- adverse effects : Lymph Node Excision.
- etiology : Lymphedema.
- therapy : Lymphedema, Postoperative Complications.
- Evidence-Based Medicine, Humans, Patient Care Team, Practice Guidelines as Topic.
Abstract
Lymphedema is divided into primary lymphedema due to inherited conditions, and secondary lymphedema arising from damage to the lymph nodes or vessels. The main cause of secondary lymphedema in Japan is cancer treatment such as lymph node dissection and/or irradiation. However, surgeons are not often interested in this non-fatal aftereffect of surgery. Therefore, there has been little research with a high level of evidence to reach a better evidence-based medicine(EBM)or understanding of the real incidence of lymphedema. Because of the delay of standardization of management, prophylactic instruction against lymphedema and the use of elastic garments and bandaging for the treatment of lymphedema have been covered by medical reimbursement since 2008. Doctors must now pay attention to the management of postoperative lymphedema. Prophylactic instructions are given to doctors, nurses, and physical therapists so that they may teach the prescribed points to patients independently. These medical staff are also supposed to be in charge of the treatment of lymphedema patients; however, only the costs of compression materials have been reimbursed as of 2013. A standard strategy based on the EBM should be performed as a team practice. A comprehensive program including lymphedema management is also introduced.
PubMed: 24423945
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001727
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :001727
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001727
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :006176
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :006176
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :006176
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :002288
Links to Exploration step
pubmed:24423945Curation
No country items
Kaoru Kitamura<affiliation><nlm:affiliation>General Incorporated Association Lymphedema Technician Training Academy.</nlm:affiliation>
<wicri:noCountry code="no comma">General Incorporated Association Lymphedema Technician Training Academy.</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Team medical care for lymphedema management from evidence-based medicine].</title>
<author><name sortKey="Kitamura, Kaoru" sort="Kitamura, Kaoru" uniqKey="Kitamura K" first="Kaoru" last="Kitamura">Kaoru Kitamura</name>
<affiliation><nlm:affiliation>General Incorporated Association Lymphedema Technician Training Academy.</nlm:affiliation>
<wicri:noCountry code="no comma">General Incorporated Association Lymphedema Technician Training Academy.</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Kawamoto, Miyuki" sort="Kawamoto, Miyuki" uniqKey="Kawamoto M" first="Miyuki" last="Kawamoto">Miyuki Kawamoto</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24423945</idno>
<idno type="pmid">24423945</idno>
<idno type="wicri:Area/PubMed/Corpus">001727</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001727</idno>
<idno type="wicri:Area/PubMed/Curation">001727</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001727</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001727</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001727</idno>
<idno type="wicri:Area/Ncbi/Merge">006176</idno>
<idno type="wicri:Area/Ncbi/Curation">006176</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">006176</idno>
<idno type="wicri:doubleKey">0385-0684:2014:Kitamura K:team:medical:care</idno>
<idno type="wicri:Area/Main/Merge">002288</idno>
<idno type="wicri:Area/Main/Curation">002285</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Team medical care for lymphedema management from evidence-based medicine].</title>
<author><name sortKey="Kitamura, Kaoru" sort="Kitamura, Kaoru" uniqKey="Kitamura K" first="Kaoru" last="Kitamura">Kaoru Kitamura</name>
<affiliation><nlm:affiliation>General Incorporated Association Lymphedema Technician Training Academy.</nlm:affiliation>
<wicri:noCountry code="no comma">General Incorporated Association Lymphedema Technician Training Academy.</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Kawamoto, Miyuki" sort="Kawamoto, Miyuki" uniqKey="Kawamoto M" first="Miyuki" last="Kawamoto">Miyuki Kawamoto</name>
</author>
</analytic>
<series><title level="j">Gan to kagaku ryoho. Cancer & chemotherapy</title>
<idno type="ISSN">0385-0684</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Evidence-Based Medicine</term>
<term>Humans</term>
<term>Lymph Node Excision (adverse effects)</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (therapy)</term>
<term>Patient Care Team</term>
<term>Postoperative Complications (therapy)</term>
<term>Practice Guidelines as Topic</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Complications postopératoires ()</term>
<term>Guides de bonnes pratiques cliniques comme sujet</term>
<term>Humains</term>
<term>Lymphadénectomie (effets indésirables)</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (étiologie)</term>
<term>Médecine factuelle</term>
<term>Équipe soignante</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lymphadénectomie</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Evidence-Based Medicine</term>
<term>Humans</term>
<term>Patient Care Team</term>
<term>Practice Guidelines as Topic</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Complications postopératoires</term>
<term>Guides de bonnes pratiques cliniques comme sujet</term>
<term>Humains</term>
<term>Lymphoedème</term>
<term>Médecine factuelle</term>
<term>Équipe soignante</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Lymphedema is divided into primary lymphedema due to inherited conditions, and secondary lymphedema arising from damage to the lymph nodes or vessels. The main cause of secondary lymphedema in Japan is cancer treatment such as lymph node dissection and/or irradiation. However, surgeons are not often interested in this non-fatal aftereffect of surgery. Therefore, there has been little research with a high level of evidence to reach a better evidence-based medicine(EBM)or understanding of the real incidence of lymphedema. Because of the delay of standardization of management, prophylactic instruction against lymphedema and the use of elastic garments and bandaging for the treatment of lymphedema have been covered by medical reimbursement since 2008. Doctors must now pay attention to the management of postoperative lymphedema. Prophylactic instructions are given to doctors, nurses, and physical therapists so that they may teach the prescribed points to patients independently. These medical staff are also supposed to be in charge of the treatment of lymphedema patients; however, only the costs of compression materials have been reimbursed as of 2013. A standard strategy based on the EBM should be performed as a team practice. A comprehensive program including lymphedema management is also introduced.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002285 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 002285 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Curation |type= RBID |clé= pubmed:24423945 |texte= [Team medical care for lymphedema management from evidence-based medicine]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:24423945" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |